{"id":{"repo_id":"etsu","oai_identifier":"oai:dc.etsu.edu:etd-5916"},"canonical_url":"https://search.ndltd.org/etd/etsu/oai:dc.etsu.edu:etd-5916","repository":{"repo_id":"etsu","name":"East Tennessee State University","base_url":"https://dc.etsu.edu/do/oai/"},"display":{"title":"Exogenous Ubiquitin: Role in Myocardial Ischemia/Reperfusion Injury, and Macrophage Phenotype and Function","abstract":"Ischemic heart disease is a leading cause of death worldwide. Ubiquitin (UB), an evolutionary conserved protein, is found in all eukaryotic cells. Previous work has shown that treatment of mice with exogenous UB (eUB) reduces inflammatory response and preserves heart function 3 days following ischemia/reperfusion injury (I/R). This study investigated the long-term (28 days post-I/R) cardioprotective potential of eUB using a mouse model of myocardial I/R; and tested the hypothesis that eUB modulates phenotype and function of macrophages (key cells involved in inflammation post-I/R) using thioglycolate-elicited mouse peritoneal macrophages. Heart function measured at 3, 7, 14 and 28 days post-I/R using echocardiography showed that eUB improves heart function throughout the observation period, and decreases I/R-mediated increase in left ventricular dilation at 3, 14 and 28 days timepoints. Myocardial fibrosis, hypertrophy and apoptosis were lower in eUB-treated hearts 28 days post-I/R. These changes in the heart associated with decreased expression of fibrosis-related proteins (collagen-1α1 and MMP-2) and hypertrophy-related protein (MYH-7B) in UB-treated hearts. Activation of GSK3β (pro-apoptotic kinase) was lower (vs. Sham), while activation of anti-apoptotic kinases, ERK1/2 (vs. I/R) and Akt (vs. Sham), was higher in eUB-treated hearts 28 days post-I/R. Serum levels of IL-6, IL-2 and G-CSF were lower in I/R+UB vs. I/R group 28 days post-I/R. In peritoneal macrophages, eUB induced cytoskeleton reorganization in M1-polarized (IFNγ treatment for 72 hours; 100U/mL) and M2-polarized (IL-4 treatment for 72 hours; 20ng/mL) cells. eUB decreased secretion of IL-1β and TNFα in M1-polarized macrophages, while it decreased secretion of TNFα, IL-10 and GM-CSF in M2-polarized macrophages. Efferocytosis was lower in eUB-treated M2-polarized macrophages, which was reversed by CXCR4 receptor antagonist (AMD3100). eUB enhanced migration of M1-polarized macrophages, while it decreased the migration of M2-polarized macrophages. AMD3100 negated the effects of eUB on M1-polarized macrophage migration. eUB decreased activation of STAT1 and FAK, while increasing activation of ERK1/2 in M1-polarized macrophages. In M2-polarized macrophages, eUB decreased Akt activation. Thus, UB treatment preserves heart function and decreases adverse cardiac remodeling 28 days post-I/R. In polarized macrophages, eUB reduces secretion of inflammatory cytokines, and alters phenotype and function of M1- and M2-polarized macrophages.","abstract_html":"Ischemic heart disease is a leading cause of death worldwide. Ubiquitin (UB), an evolutionary conserved protein, is found in all eukaryotic cells. Previous work has shown that treatment of mice with exogenous UB (eUB) reduces inflammatory response and preserves heart function 3 days following ischemia/reperfusion injury (I/R). This study investigated the long-term (28 days post-I/R) cardioprotective potential of eUB using a mouse model of myocardial I/R; and tested the hypothesis that eUB modulates phenotype and function of macrophages (key cells involved in inflammation post-I/R) using thioglycolate-elicited mouse peritoneal macrophages. Heart function measured at 3, 7, 14 and 28 days post-I/R using echocardiography showed that eUB improves heart function throughout the observation period, and decreases I/R-mediated increase in left ventricular dilation at 3, 14 and 28 days timepoints. Myocardial fibrosis, hypertrophy and apoptosis were lower in eUB-treated hearts 28 days post-I/R. These changes in the heart associated with decreased expression of fibrosis-related proteins (collagen-1α1 and MMP-2) and hypertrophy-related protein (MYH-7B) in UB-treated hearts. Activation of GSK3β (pro-apoptotic kinase) was lower (vs. Sham), while activation of anti-apoptotic kinases, ERK1/2 (vs. I/R) and Akt (vs. Sham), was higher in eUB-treated hearts 28 days post-I/R. Serum levels of IL-6, IL-2 and G-CSF were lower in I/R+UB vs. I/R group 28 days post-I/R. In peritoneal macrophages, eUB induced cytoskeleton reorganization in M1-polarized (IFNγ treatment for 72 hours; 100U/mL) and M2-polarized (IL-4 treatment for 72 hours; 20ng/mL) cells. eUB decreased secretion of IL-1β and TNFα in M1-polarized macrophages, while it decreased secretion of TNFα, IL-10 and GM-CSF in M2-polarized macrophages. Efferocytosis was lower in eUB-treated M2-polarized macrophages, which was reversed by CXCR4 receptor antagonist (AMD3100). eUB enhanced migration of M1-polarized macrophages, while it decreased the migration of M2-polarized macrophages. AMD3100 negated the effects of eUB on M1-polarized macrophage migration. eUB decreased activation of STAT1 and FAK, while increasing activation of ERK1/2 in M1-polarized macrophages. In M2-polarized macrophages, eUB decreased Akt activation. Thus, UB treatment preserves heart function and decreases adverse cardiac remodeling 28 days post-I/R. In polarized macrophages, eUB reduces secretion of inflammatory cytokines, and alters phenotype and function of M1- and M2-polarized macrophages.","abstract_has_math":false,"creators":["Shook, Paige"],"institution":"East Tennessee State University","degree_name":"PhD (Doctor of Philosophy)","degree_level":"Dissertation - restricted","degree_discipline":"Biomedical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-05-01T07:00:00Z","date_published":"2024-05-01T07:00:00Z","updated_at":"2026-11-19T07:57:02Z","subjects":["Ubiquitin","ischemia/reperfusion","cardiac","remodeling","inflammation","macrophage","Biology","Cell Biology","Life Sciences"],"languages":["eng"],"rights":["Copyright by the authors."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dc.etsu.edu/etd/4394","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dc.etsu.edu/etd/4394","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":"https://dc.etsu.edu/context/etd/article/5916/viewcontent/ShookP042424f.pdf","download_label":"Download PDF","download_source":"dc:identifier","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dc.etsu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adc.etsu.edu%3Aetd-5916","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Shook, Paige"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-06-15T07:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["East Tennessee State University"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation - restricted"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD (Doctor of Philosophy)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["East Tennessee State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Ubiquitin","ischemia/reperfusion","cardiac","remodeling","inflammation","macrophage","Biology","Cell Biology","Life Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright by the authors."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dc.etsu.edu/context/etd/article/5916/viewcontent/ShookP042424f.pdf","https://dc.etsu.edu/etd/4394"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Ischemic heart disease is a leading cause of death worldwide. Ubiquitin (UB), an evolutionary conserved protein, is found in all eukaryotic cells. Previous work has shown that treatment of mice with exogenous UB (eUB) reduces inflammatory response and preserves heart function 3 days following ischemia/reperfusion injury (I/R). This study investigated the long-term (28 days post-I/R) cardioprotective potential of eUB using a mouse model of myocardial I/R; and tested the hypothesis that eUB modulates phenotype and function of macrophages (key cells involved in inflammation post-I/R) using thioglycolate-elicited mouse peritoneal macrophages. Heart function measured at 3, 7, 14 and 28 days post-I/R using echocardiography showed that eUB improves heart function throughout the observation period, and decreases I/R-mediated increase in left ventricular dilation at 3, 14 and 28 days timepoints. Myocardial fibrosis, hypertrophy and apoptosis were lower in eUB-treated hearts 28 days post-I/R. These changes in the heart associated with decreased expression of fibrosis-related proteins (collagen-1α1 and MMP-2) and hypertrophy-related protein (MYH-7B) in UB-treated hearts. Activation of GSK3β (pro-apoptotic kinase) was lower (vs. Sham), while activation of anti-apoptotic kinases, ERK1/2 (vs. I/R) and Akt (vs. Sham), was higher in eUB-treated hearts 28 days post-I/R. Serum levels of IL-6, IL-2 and G-CSF were lower in I/R+UB vs. I/R group 28 days post-I/R. In peritoneal macrophages, eUB induced cytoskeleton reorganization in M1-polarized (IFNγ treatment for 72 hours; 100U/mL) and M2-polarized (IL-4 treatment for 72 hours; 20ng/mL) cells. eUB decreased secretion of IL-1β and TNFα in M1-polarized macrophages, while it decreased secretion of TNFα, IL-10 and GM-CSF in M2-polarized macrophages. Efferocytosis was lower in eUB-treated M2-polarized macrophages, which was reversed by CXCR4 receptor antagonist (AMD3100). eUB enhanced migration of M1-polarized macrophages, while it decreased the migration of M2-polarized macrophages. AMD3100 negated the effects of eUB on M1-polarized macrophage migration. eUB decreased activation of STAT1 and FAK, while increasing activation of ERK1/2 in M1-polarized macrophages. In M2-polarized macrophages, eUB decreased Akt activation. Thus, UB treatment preserves heart function and decreases adverse cardiac remodeling 28 days post-I/R. In polarized macrophages, eUB reduces secretion of inflammatory cytokines, and alters phenotype and function of M1- and M2-polarized macrophages."]},{"key":"dc:title","label":"Title","values":["Exogenous Ubiquitin: Role in Myocardial Ischemia/Reperfusion Injury, and Macrophage Phenotype and Function"]}]}],"canonical_facts":{"dc:creator":["Shook, Paige"],"dc:date.available":["2025-06-15T07:00:00Z"],"dc:date.issued":["2024-05-01T07:00:00Z"],"dc:description.abstract":["Ischemic heart disease is a leading cause of death worldwide. Ubiquitin (UB), an evolutionary conserved protein, is found in all eukaryotic cells. Previous work has shown that treatment of mice with exogenous UB (eUB) reduces inflammatory response and preserves heart function 3 days following ischemia/reperfusion injury (I/R). This study investigated the long-term (28 days post-I/R) cardioprotective potential of eUB using a mouse model of myocardial I/R; and tested the hypothesis that eUB modulates phenotype and function of macrophages (key cells involved in inflammation post-I/R) using thioglycolate-elicited mouse peritoneal macrophages. Heart function measured at 3, 7, 14 and 28 days post-I/R using echocardiography showed that eUB improves heart function throughout the observation period, and decreases I/R-mediated increase in left ventricular dilation at 3, 14 and 28 days timepoints. Myocardial fibrosis, hypertrophy and apoptosis were lower in eUB-treated hearts 28 days post-I/R. These changes in the heart associated with decreased expression of fibrosis-related proteins (collagen-1α1 and MMP-2) and hypertrophy-related protein (MYH-7B) in UB-treated hearts. Activation of GSK3β (pro-apoptotic kinase) was lower (vs. Sham), while activation of anti-apoptotic kinases, ERK1/2 (vs. I/R) and Akt (vs. Sham), was higher in eUB-treated hearts 28 days post-I/R. Serum levels of IL-6, IL-2 and G-CSF were lower in I/R+UB vs. I/R group 28 days post-I/R. In peritoneal macrophages, eUB induced cytoskeleton reorganization in M1-polarized (IFNγ treatment for 72 hours; 100U/mL) and M2-polarized (IL-4 treatment for 72 hours; 20ng/mL) cells. eUB decreased secretion of IL-1β and TNFα in M1-polarized macrophages, while it decreased secretion of TNFα, IL-10 and GM-CSF in M2-polarized macrophages. Efferocytosis was lower in eUB-treated M2-polarized macrophages, which was reversed by CXCR4 receptor antagonist (AMD3100). eUB enhanced migration of M1-polarized macrophages, while it decreased the migration of M2-polarized macrophages. AMD3100 negated the effects of eUB on M1-polarized macrophage migration. eUB decreased activation of STAT1 and FAK, while increasing activation of ERK1/2 in M1-polarized macrophages. In M2-polarized macrophages, eUB decreased Akt activation. Thus, UB treatment preserves heart function and decreases adverse cardiac remodeling 28 days post-I/R. In polarized macrophages, eUB reduces secretion of inflammatory cytokines, and alters phenotype and function of M1- and M2-polarized macrophages."],"dc:identifier":["https://dc.etsu.edu/context/etd/article/5916/viewcontent/ShookP042424f.pdf","https://dc.etsu.edu/etd/4394"],"dc:language":["eng"],"dc:publisher":["East Tennessee State University"],"dc:rights":["Copyright by the authors."],"dc:subject":["Ubiquitin","ischemia/reperfusion","cardiac","remodeling","inflammation","macrophage","Biology","Cell Biology","Life Sciences"],"dc:title":["Exogenous Ubiquitin: Role in Myocardial Ischemia/Reperfusion Injury, and Macrophage Phenotype and Function"],"thesis:degree_discipline":["Biomedical Sciences"],"thesis:degree_level":["Dissertation - restricted"],"thesis:degree_name":["PhD (Doctor of Philosophy)"],"thesis:institution_name":["East Tennessee State University"]},"updated_at":"2026-11-19T07:57:02Z"}